Cystic fibrosis year in review 2022

Area of Science:

• Medical research
• Pulmonology
• Genetics

Background:

• Significant advancements in cystic fibrosis (CF) care have emerged recently.
• Ongoing research addresses challenges like limited access to CFTR modulators and the impact of the COVID-19 pandemic.
• There is a continuous effort to enhance CF screening, disease burden understanding, diagnosis, and management strategies.

Purpose of the Study:

• To review clinically relevant studies published in 2022 concerning cystic fibrosis.
• To provide a comprehensive overview of the latest research in CF.
• To highlight advancements and ongoing challenges in CF management and treatment.

Main Methods:

• Systematic review of literature published in 2022.
• Focus on clinically relevant studies related to cystic fibrosis.
• Synthesis of research findings on CF screening, diagnosis, management, and CFTR modulators.

Main Results:

• The year 2022 saw continued progress in understanding and managing cystic fibrosis.
• Research emphasized improving access to and effectiveness of CFTR modulators.
• Studies also focused on refining screening protocols and addressing the disease burden in the context of the COVID-19 pandemic.

Conclusions:

• The review provides a snapshot of key 2022 research in cystic fibrosis.
• Continued research is vital for overcoming barriers to effective CFTR modulator therapy and improving patient outcomes.
• Efforts to optimize CF screening, diagnosis, and management remain critical for the CF community.